In September 1995, the FDA originally accredited testosterone transdermal patches (Androderm); quite a few transdermal varieties and types are actually offered which include implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA approved in July 2003; the system can be a mucoadhesive solution that adheres towards the